We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
24 hedge funds and large institutions have $8.68M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% less funds holding
Funds holding: 26 → 24 (-2)
23% less capital invested
Capital invested by funds: $11.2M → $8.68M (-$2.54M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$254K |
| 2 |
RA
Royce & Associates
New York
|
-$117K |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$51K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$48.4K |
| 5 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$32.2K |